West Pharmaceutical Services Inc (WST) stock news · P/E 50, rev $3.07B
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
This WST news page leads with what West Pharmaceutical Services Inc filed — not a scraped headline mill.
No cached 8-K sentence for WST yet. We will not pad this page with generic market recap.
Latest reported WST revenue for 2025-12-31 was $3.07B. Net income was $493.7M. Revenue was up 6.3% from 2024-12-31 to 2025-12-31. WST currently screens at market cap $15.97B and trailing P/E 50.2.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the WST stock page; for the tape open the quote page.
WST stock news FAQ
What are WST's latest revenue and net income?
Latest cached West Pharmaceutical Services Inc (WST) revenue for Dec 31, 2025 was $3.07B. Net income was $493.7M. Statements: https://lician.com/financials/wst
How did WST revenue change from the prior cached period?
Cached West Pharmaceutical Services Inc (WST) revenue was up 6.3% from $2.89B (Dec 31, 2024) to $3.07B (Dec 31, 2025). Statements: https://lician.com/financials/wst
What is WST's P/E ratio?
West Pharmaceutical Services Inc (WST) trailing P/E is 50.2 on the latest cached fundamentals snapshot.
What is WST's market cap?
West Pharmaceutical Services Inc (WST) market cap is $15.97B on the latest cached fundamentals snapshot.
What kind of company is WST?
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Where is WST stock news listed?
Cached stock news for West Pharmaceutical Services Inc (WST) is listed at https://lician.com/news/wst. Filings: https://lician.com/sec/wst
Not investment advice.